(116 days)
Not Found
No
The summary describes a device that uses ECG signals to locate a catheter tip, but there is no mention of AI or ML in the device description, intended use, or performance studies.
No
The device is used for positioning and confirming the tip location of Peripherally Inserted Catheters (PICC), not for treating a disease or condition.
No
The device is used to confirm the placement of a catheter tip, not to diagnose a medical condition or disease.
No
The device description explicitly lists hardware components such as the Celerity Monitor, ECG Patient Cable, Remote Control Cable, Battery, Power Supply Cord, and ECG Clip Cable.
Based on the provided information, the Celerity System is not an In Vitro Diagnostic (IVD) device.
Here's why:
- Intended Use: The intended use is for the positioning and real-time location of a medical device (PICC) within the patient's body. It uses the patient's physiological signals (cardiac electrical activity) to guide a procedure.
- Mechanism of Action: The device analyzes the patient's ECG to determine the location of the PICC tip relative to the heart. This is a direct measurement of a physiological signal, not an analysis of a sample taken from the body.
- Lack of Sample Analysis: IVD devices are designed to examine specimens derived from the human body (like blood, urine, tissue, etc.) to provide information for diagnosis, monitoring, or screening. The Celerity System does not analyze any such samples.
The Celerity System is a medical device used for guiding a medical procedure and confirming the placement of another medical device within the patient's body. It falls under the category of devices that interact directly with the patient's physiology.
N/A
Intended Use / Indications for Use
The Celerity System is indicated for the positioning of Peripherally Inserted Catheters (PICC) in adult patients. It provides real-time catheter tip location by using the patient's cardiac electrical activity. The Celerity System is indicated for use as an alternative nethod to chest x-ray or fluoroscopy confirmation of PICC tip placement in adult patients.
Note: In general, devices that utilize ECG technique to observe P-Wave are limited, but not contraindicated, for patients where cardiac rhythms may change presentation of the P-Wave; including,
-Atrial fibrillation
-Atrial flutter
-Severe tachycardia
-Pacemaker-driven rhythm
- Chronic obstructive pulmonary disease (COPD)
Such patients are easily identified prior to PCC insertion. Use of an additional confirmation method is necessary to confirm catheter tip location.
Product codes (comma separated list FDA assigned to the subject device)
LJS
Device Description
The Celerity System includes the Celerity Monitor/Software, ECG Patient Cable, Remote Control Cable, Battery, Power Supply Cord and ECG Clip Cable (alligator clip). Procedural accessories including ECG Snap Leads, Surface Electrodes, Cable Cover and Prep Pads are provided as a convenience for the clinician.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
adult patients
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Simulated Use / Human Factors Testing has been conducted to evaluate the application of the Celerity electrocardiogram (ECG)-Based Tip Confirmation System (i.e., Celerity System) when used to confirm PICC tip position as an alternative method to chest X-ray or fluoroscopy confirmation. The use related events noted in the studies have been adequately reviewed and addressed in order to ensure the safe, effective use of the device as an alternate to x-ray techniques for confirmation of tip location of PICC. Based on the content of the proposed Celerity System's Risk Analysis / Use and Design FMEAs, and the content of the Instructions for Use, the Celerity System has demonstrated its suitability for its intended purpose.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K140799 CelerityTM System, K093775 Sapiens TM Tip Location System
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 880.5970 Percutaneous, implanted, long-term intravascular catheter.
(a)
Identification. A percutaneous, implanted, long-term intravascular catheter is a device that consists of a slender tube and any necessary connecting fittings, such as luer hubs, and accessories that facilitate the placement of the device. The device allows for repeated access to the vascular system for long-term use of 30 days or more, and it is intended for administration of fluids, medications, and nutrients; the sampling of blood; and monitoring blood pressure and temperature. The device may be constructed of metal, rubber, plastic, composite materials, or any combination of these materials and may be of single or multiple lumen design.(b)
Classification. Class II (special controls) Guidance Document: “Guidance on Premarket Notification [510(k)] Submission for Short-Term and Long-Term Intravascular Catheters.”
0
Image /page/0/Picture/1 description: The image shows the seal for the Department of Health & Human Services USA. The seal features the department's name in a circular arrangement around a stylized eagle. The eagle is depicted with its wings spread, symbolizing protection and service.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
February 5, 2015
AngioDynamics Inc. Mr. Michael P. Hanley Specialist, Global Regulatory Affairs 26 Forest Street Marlborough, MA 01752
Re: K142889
Trade/Device Name: CelerityTM PICCTip Confirmation System Regulation Number: 21 CFR 880.5970 Regulation Name: Percutaneous, implanted, long-term intravascular catheter Regulatory Class: II Product Code: LJS Dated: December 12, 2014 Received: December 15, 2014
Dear Mr. Hanley:
This letter corrects our substantially equivalent letter of January 27, 2015.
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drue, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must
1
Page 2 - Mr. Michael P. Hanley
comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801 ); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part . 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Tina
Kiang -S
for Erin I. Keith, M.S. Director Division of Anesthesiology, General Hospital, Respiratory, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.
510(k) Number (if known) K142889
Device Name Celerity PICC Tip Configuration System
Indications for Use (Describe)
The Celerity System is indicated for the positioning of Peripherally Inserted Catheters (PICC) in adult patients. It provides real-time catheter tip location by using the patient's cardiac electrical activity. The Celerity System is indicated for use as an alternative nethod to chest x-ray or fluoroscopy confirmation of PICC tip placement in adult patients.
Note: In general, devices that utilize ECG technique to observe P-Wave are limited, but not contraindicated, for patients where cardiac rhythms may change presentation of the P-Wave; including,
-Atrial fibrillation
-Atrial flutter
-Severe tachycardia
-Pacemaker-driven rhythm
- Chronic obstructive pulmonary disease (COPD)
Such patients are easily identified prior to PCC insertion. Use of an additional confirmation method is necessary to confirm catheter tip location.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON A SEPARATE PAGE IF NEEDED.
10 - 11 - 11 FOR FDA USE ONLY Concurrence of Center for Devices and Radiological Health (CDRH) (Signature)
3
Image /page/3/Picture/0 description: The image shows the word "angiodynamics" in a sans-serif font. To the left of the word is a logo that appears to be a stylized, abstract shape. The logo is black and white and has a three-dimensional appearance.
510(k) Summary : K142889
:
Date Prepared: October 01, 2014
| A. | Submitter Information | |||
|---|---|---|---|---|
| Submitter: | Angiodynamics Inc. | |||
| 26 Forest St | ||||
| Marlborough, MA 01752 | ||||
| Tel: | (508) 263-7983 | |||
| Fax: | (508) 263-9732 | |||
| Contact: | Michael Hanley, Specialist, Global | |||
| Regulatory Affairs | ||||
| Email: | MHanley@angiodynamics.com | |||
| Or: | ||||
| Linda Varroso | ||||
| AngioDynamics, Inc. | ||||
| 26 Forest Street | ||||
| Marlborough, MA 01752 | ||||
| Tel: | (508) 658-7967 | |||
| Fax: | (508) 263-9723 | |||
| Email: | lvarroso@angiodynamics.com | |||
| B. | Trade Name | Trade Name: | Celerity™ PICC Tip Confirmation System | |
| Common Name: | PICC placement accessory | |||
| Classification Name: | ||||
| intravascular Catheter | Percutaneous, implanted, long-term | |||
| Product Code: | LJS, 21CFR 880.5970 | |||
| Class: | II | |||
| C. | Predicate Devices | K140799 Celerity™ System | ||
| K093775 Sapiens ™ Tip Location System | ||||
| Common Name: PICC placement accessory | ||||
| Classification Name: Percutaneous, implanted, long-term intravascular | ||||
| Catheter | ||||
| Product Code: LJS, 21CFR 880.5970 | ||||
| Class: II | ||||
| D. | Device Description | |||
| The Celerity System includes the Celerity Monitor/Software, ECG Patient | ||||
| Cable, Remote Control Cable, Battery, Power Supply Cord and ECG Clip | ||||
| Cable (alligator clip). Procedural accessories including ECG Snap Leads, | ||||
| Surface Electrodes, Cable Cover and Prep Pads are provided as a | ||||
| convenience for the clinician. | ||||
| E. | Intended Use | |||
| The Celerity System is intended to provide real time tip location | ||||
| information of a central venous catheter by utilization of ECG to observe |
4
Image /page/4/Picture/0 description: The image shows the word "angiodynamics" in black font. To the left of the word is a logo that appears to be a stylized representation of blood vessels or a similar biological structure. The logo is also in black and has a three-dimensional appearance.
P-wave changes as the tip approaches the right atrium of the heart via the superior vena cava.
F. Indications for Use
The Celerity System is indicated for the positioning of Peripherally Inserted Central Catheters (PICC) in adult patients. It provides real-time catheter tip location information by using the patient's cardiac electrical activity. The Celerity System is indicated for use as an alternative method to chest X-ray or fluoroscopy confirmation of PICC tip placement in adult patients.
Note: In general, devices that utilize ECG technique to observe P-wave are limited, but not contraindicated, for patients where cardiac rhythms may change presentation of the P-Wave: -Atrial fibrillation -Atrial flutter -Severe tachycardia -Pacemaker-driven rhythm -Chronic obstructive pulmonary disease (COPD)
Such patients are easily identified prior to PICC insertion. Use of an additional confirmation method is necessary to confirm catheter tip location.
Technological Characteristics G.
:
Technological Characteristics of the subject Celerity are equivalent with respect to the basic system design and function to that of the predicate device. The differences between the predicate and proposed devices do not raise new questions of safety or effectiveness.
H. Safety and Performance
The results of Design Verification and Validation activities were performed in accordance with Design Control requirements per 21 CFR 820.30 and demonstrate that the subject Celerity System meets predetermined performance specifications.
The performance evaluation plan included testing per the following recognized standards to assess conformance to IEC 60601 (300 Edition).
- IEC 60601-1 Medical Electrical Equipment – Part 1: General Requirements for Safety Medical Electrical Equipment – Part 2: General IEC 60601-1-2 Requirements for Basic Safety and Essential Performance – Collateral Standard Electro Magnetic Compatibility - Requirements and Test
5
Image /page/5/Picture/0 description: The image shows the word "angiodynamics" in black font. To the left of the word is a logo that appears to be a stylized representation of interconnected shapes. The logo is also in black and is positioned to the left of the company name.
December 12, 2014 Re: K142889-Supplement
Human Factors Evaluation - Simulated Use Testing alternate to chest xray and fluoroscopy:
Simulated Use / Human Factors Testing has been conducted to evaluate the application of the Celerity electrocardiogram (ECG)-Based Tip Confirmation System (i.e., Celerity System) when used to confirm PICC tip position as an alternative method to chest X-ray or fluoroscopy confirmation. The use related events noted in the studies have been adequately reviewed and addressed in order to ensure the safe, effective use of the device as an alternate to x-ray techniques for confirmation of tip location of PICC. Based on the content of the proposed Celerity System's Risk Analysis / Use and Design FMEAs, and the content of the Instructions for Use, the Celerity System has demonstrated its suitability for its intended purpose.
l. Substantial Equivalence Conclusion
The proposed device is determined to be substantially equivalent to the predicate device based on:
- The Intended Use and Indications for Use
- . Operating principles/technology
- Results of safety and performance testing ●
- Responses to questions posed in FDA 510(k) "Substantial Equivalence" Decision-Making Flowchart